Patent Protection in Medicine and Biotechnology: An Overview.
- Published in:
- Journal of Health & Life Sciences Law, 2011, v. 4, n. 3, p. 106
- By:
- Publication type:
- Article
Works matching DE "WRITTEN description requirement (Patent law)"
Results: 7
1
2
INNOVATION ON THE CUTTING EDGE OF ARIAD: REINVENTING THE WRITTEN DESCRIPTION REQUIREMENT.
- Published in:
- New York University Law Review, 2011, v. 86, n. 6, p. 1895
- By:
- Publication type:
- Article
3
THE EN BANC FEDERAL CIRCUIT'S WRITTEN DESCRIPTION REQUIREMENT: TIME FOR THE SUPREME COURT TO REVERSE AGAIN?
- Published in:
- Cardozo Law Review, 2012, v. 33, n. 3, p. 895
- By:
- Publication type:
- Article
4
ARIAD PHARMACEUTICALS, INC. V. ELI LILLYAND Co.
- Published in:
- Berkeley Technology Law Journal, 2011, v. 26, n. 1, p. 367
- Publication type:
- Article
5
UNIVERSITYOF ROCHESTER v. G.D. SEARLE & Co. 358 F.3d 916 (Fed. Cir), reh'g en banc denied, 375 F.3d 1303, cert. denied, 160 L Ed. 2d 484 (2004).
- Published in:
- Berkeley Technology Law Journal, 2005, v. 20, n. 1, p. 183
- Publication type:
- Article
6
ENCOURAGING FURTHER INNOVATION: ARIAD v. ELI LILLY AND THE WRITTEN DESCRIPTION REQUIREMENT.
- Published in:
- Seton Hall Law Review, 2012, v. 42, n. 3, p. 1287
- By:
- Publication type:
- Article
7
IMMATERIAL TO INNOVATION: THE STORY OF ARIAD PHARMACEUTICALS, INC. V. ELI LILLY & CO.
- Published in:
- Brooklyn Journal of Corporate, Financial & Commercial Law, 2011, v. 5, n. 2, p. 503
- By:
- Publication type:
- Article